Meloxicam Normon (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for producing prostaglandins that drive inflammation, pain, and fever. By limiting prostaglandin formation, meloxicam diminishes these symptoms while preserving some COX‑1 activity that protects the stomach lining.

The appropriate dose of Meloxicam Normon is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the exact dosage instructions provided by their prescriber and not adjust the dose on their own.

Safety data for meloxicam in pregnancy and lactation are limited, and the drug is generally classified as contraindicated unless the potential benefit justifies the risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Meloxicam offers more selective COX‑2 inhibition than non‑selective NSAIDs like ibuprofen, which can translate into a lower incidence of gastrointestinal irritation for some patients. However, both drug classes share similar cardiovascular and renal risk profiles, and the choice depends on individual patient factors and physician judgment.

Meloxicam Normon should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the tablets in their original container, protect them from moisture, heat, and direct sunlight, and ensure they are out of reach of children.

Meloxicam Normon is taken orally, usually with a full glass of water. It can be taken with or without food, but patients who experience stomach upset may benefit from taking it with meals. The tablet should be swallowed whole and not crushed or chewed.

The most serious adverse events include gastrointestinal ulceration or bleeding, cardiovascular complications such as heart attack or stroke, severe renal impairment, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored closely for signs of these conditions.

Meloxicam is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients with severe heart failure, and anyone who has had a recent myocardial infarction. It should also be avoided in patients with severe renal or hepatic impairment unless specifically directed by a physician.